Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$531M |
| 2 |
Kinder Morgan
KMI
|
+$496M |
| 3 |
IBM
IBM
|
+$253M |
| 4 |
CA
CA, Inc.
CA
|
+$213M |
| 5 |
Estee Lauder
EL
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$381M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$351M |
| 4 |
Apple
AAPL
|
+$333M |
| 5 |
Johnson & Johnson
JNJ
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.32% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.97% |
| 4 | Industrials | 10.35% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Mercury Systems
MRCY
$6.67B
| $5.13M | ﹤0.01% |
368,676
-18,802
| -5% | -$241K |
|
|
RJET
2302
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $5.13M | ﹤0.01% |
351,413
-6,540
| -2% | -$80.6K |
|
2303
MaxLinear
MXL
$7.69B
| $5.1M | ﹤0.01% |
688,576
+561,841
| +443% | +$4.01M |
|
|
SGNT
2304
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $5.08M | ﹤0.01% |
202,517
-35,414
| -15% | -$1.04M |
|
2305
Forestar Group
FOR
$1.5B
| $5.08M | ﹤0.01% |
330,143
-4,606
| -1% | -$75.3K |
|
2306
National Healthcare
NHC
$3.5B
| $5.08M | ﹤0.01% |
80,897
+601
| +0.7% | +$36.1K |
|
|
LHCG
2307
DELISTED
LHC Group LLC
LHCG
| $5.08M | ﹤0.01% |
162,925
-6,398
| -4% | -$161K |
|
|
XOXO
2308
DELISTED
Xo Group Inc
XOXO
| $5.08M | ﹤0.01% |
278,957
-44,571
| -14% | -$630K |
|
|
RSE
2309
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $5.07M | ﹤0.01% |
273,676
+37,589
| +16% | +$665K |
|
2310
Scorpio Tankers
STNG
$3.98B
| $5.05M | ﹤0.01% |
58,150
-2,569
| -4% | -$213K |
|
2311
Precigen
PGEN
$2.18B
| $5.04M | ﹤0.01% |
191,541
+8,864
| +5% | +$194K |
|
|
LORL
2312
DELISTED
Loral Space and Communications, Inc.
LORL
| $5.03M | ﹤0.01% |
63,936
-5,287
| -8% | -$398K |
|
|
HDV
2313
iShares Core High Dividend ETF
HDV
$15.1B
| $5.03M | ﹤0.01% |
328,360
+255
| +0.1% | +$3.89K |
|
|
WW
2314
DELISTED
WW International
WW
| $5.01M | ﹤0.01% |
201,789
+3,950
| +2% | +$106K |
|
|
INFI
2315
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $5M | ﹤0.01% |
295,851
-7,055
| -2% | -$103K |
|
2316
Qualys
QLYS
$6.44B
| $4.99M | ﹤0.01% |
132,264
+32,902
| +33% | +$1.1M |
|
|
BFX
2317
DELISTED
BowFlex Inc.
BFX
| $4.99M | ﹤0.01% |
328,675
-35,365
| -10% | -$472K |
|
|
BT
2318
DELISTED
BT Group plc (ADR)
BT
| $4.98M | ﹤0.01% |
160,616
-15,650
| -9% | -$478K |
|
|
IVC
2319
DELISTED
Invacare Corporation
IVC
| $4.97M | ﹤0.01% |
296,464
-7,178
| -2% | -$109K |
|
2320
Douglas Dynamics
PLOW
$976M
| $4.95M | ﹤0.01% |
230,900
-19,947
| -8% | -$428K |
|
|
SYT
2321
DELISTED
Syngenta Ag
SYT
| $4.94M | ﹤0.01% |
76,848
-185,523
| -71% | -$11.7M |
|
|
SPWR
2322
DELISTED
SunPower Corporation Common Stock
SPWR
| $4.93M | ﹤0.01% |
291,332
+23,945
| +9% | +$444K |
|
|
RPXC
2323
DELISTED
RPX Corporation
RPXC
| $4.93M | ﹤0.01% |
357,570
-3,590
| -1% | -$49.8K |
|
|
SMRT
2324
DELISTED
Stein Mart Inc
SMRT
| $4.92M | ﹤0.01% |
336,727
-2,322
| -0.7% | -$31.3K |
|
2325
iShares S&P 500 Growth ETF
IVW
$77.6B
| $4.9M | ﹤0.01% |
175,692
-3,872
| -2% | -$106K |
|
Similar funds
Bank of New York Mellon's Q4 2014 Portfolio in Review
As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
- Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
- Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
- Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
- Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
- Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.
Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.